Teva Pharmaceutical Industries LimitedTEVANYSE
LOADING
|||
Revenue Growth Trend
Above historical average, modest growth trend.
Left:
||||
Year-over-year revenue growth rate
Latest
7.28%
↑ 7827% above average
Average (39q)
0.09%
Historical baseline
Range
High:16.70%
Low:-14.31%
CAGR
+4.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 7.28% |
| Q2 2025 | 7.32% |
| Q1 2025 | -7.99% |
| Q4 2024 | -2.36% |
| Q3 2024 | 4.01% |
| Q2 2024 | 9.03% |
| Q1 2024 | -14.31% |
| Q4 2023 | 15.77% |
| Q3 2023 | -0.72% |
| Q2 2023 | 5.93% |
| Q1 2023 | -5.72% |
| Q4 2022 | 8.01% |
| Q3 2022 | -5.04% |
| Q2 2022 | 3.41% |
| Q1 2022 | -10.71% |
| Q4 2021 | 5.48% |
| Q3 2021 | -0.59% |
| Q2 2021 | -1.81% |
| Q1 2021 | -10.58% |
| Q4 2020 | 11.94% |
| Q3 2020 | 2.79% |
| Q2 2020 | -11.18% |
| Q1 2020 | -2.46% |
| Q4 2019 | 4.76% |
| Q3 2019 | -1.68% |
| Q2 2019 | 0.98% |
| Q1 2019 | -5.79% |
| Q4 2018 | 0.66% |
| Q3 2018 | -3.66% |
| Q2 2018 | -7.19% |
| Q1 2018 | -7.22% |
| Q4 2017 | -2.69% |
| Q3 2017 | -1.34% |
| Q2 2017 | 0.99% |
| Q1 2017 | -13.28% |
| Q4 2016 | 16.70% |
| Q3 2016 | 10.42% |
| Q2 2016 | 4.74% |
| Q1 2016 | -1.45% |
| Q4 2015 | 1.20% |